SEATTLE--(BUSINESS WIRE)--Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics and therapeutics, announced that the National Cancer ...

Another challenge facing test designers is that early detection may not necessarily save lives. A crucial factor, and something that is still unknown about the new multi-cancer tests, is whether they ...

Add Yahoo as a preferred source to see more of our stories on Google. WILKES-BARRE, LUZERNE COUNTY (WBRE/WYOU) — October is Breast Cancer Awareness Month, and the state’s Department of Health made a ...

The path to therapeutic cancer vaccines is strewn with disappointment. In the 20-year history of clinical trials for vaccines that are designed to treat existing cancer by stimulating the immune ...

Affinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung technology ...

In this special dedicated to Breast Cancer Awareness, One-on-One correspondent Jacqui Tricarico interviews M. Michele Blackwood, MD, FACS, Director of Breast Surgery at RWJBarnabas Health, for a ...

CEOCFO interviews NanOlogy, LLC CEO David J. Arthur on Solving Toxicity & Bioavailability Problems when Treating ...

SPT Labtech, and BellBrook Labs, announced a collaboration to advance cancer research. Together, the companies have developed a miniaturized, high-throughput screening platform for the discovery and ...

Cancer remains one of the world’s most serious health threats, especially when it spreads beyond its original site. That ...

A new technology that harnesses artificial intelligence (AI) to analyze mammograms and improve the accuracy of predicting a woman's personalized five-year risk of developing breast cancer has received ...

SPRINGFIELD — Cancer treatment has come a long way from a time when women faced the choice of either dying of untreated breast cancer or undergoing disfiguring mastectomies. Doctors can now place a ...

Elekta, a company based in Sweden, is one of the world's leaders in developing some of the most cutting-edge cancer treatment technologies — and Mary Bird Perkins Cancer Center has worked with them ...